en

PRODUCT DETAIL

Sunlenca 464 mg injekčný roztok

Code 1997E
MA number EU/1/22/1671/002
Product Form: sol inj 2x1,5 ml/463,5 mg (liek.inj.skl.+striek.inj.+ihly)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX31 Lenacapavir
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.08.2022
Validity: 17.08.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.09.2022
eu-flag.png sk-flag.png